← Leaderboards
Neda Habibi
University Of North Texas
$645,068
Attributed
$645,068
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $284.5K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$645,068 · 1
By mechanism
R16$645,068 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Estrogen Receptors”
- Amy Fowler · University Of Wisconsin-Madison$3,970,631
- Igor Landry Bado · Baylor College Of Medicine$3,507,906
- Jennifer Dupont · Tufts Medical Center$2,780,367
- Jennifer M. Rosenbluth · University Of California, San Francisco$2,657,653
- Gerson David Hernandez · University Of Arizona$2,098,361
- Konrad Hermann Stopsack · Massachusetts General Hospital$2,049,685
Research focus
Estrogen ReceptorsGrowthEnzyme SubstrateEpidermal Growth Factor ReceptorBiochemical ReactionAmino AcidsEnzyme KineticsEnzymesCancer Cell GrowthAromatase InhibitorsCancer TypeCell DeathCellsBreast Cancer CellBreast Cancer PatientEnzyme ActivityApoptosisDesignDoseDrug ResistanceDrug TargetingEffective TherapyEfficacy EvaluationHormone Therapy
Grant awards (5)
New approach based on enzyme stimulating of peptides for targeting drug resistance breast cancers$180,300
R16 · FY2025 · GM · contact PI
New approach based on enzyme stimulating of peptides for targeting drug resistance breast cancers$62,502
R16 · FY2025 · GM · contact PI
New approach based on enzyme stimulating of peptides for targeting drug resistance breast cancers$41,666
R16 · FY2025 · GM · contact PI
New approach based on enzyme stimulating of peptides for targeting drug resistance breast cancers$180,300
R16 · FY2024 · GM · contact PI
New approach based on enzyme stimulating of peptides for targeting drug resistance breast cancers$180,300
R16 · FY2023 · GM · contact PI